About this trial
The study aims to evaluate the clinical and economic efficacy of a "Fast-Track" protocol for the elective endovascular treatment (EVAR) of infrarenal abdominal aortic aneurysms (AAA). The protocol minimizes invasiveness through the use of local/locoregional anesthesia, a total percutaneous approach, and the avoidance of routine Intensive Care Unit (ICU) admission. The primary goal is to reduce hospital Length of Stay (LOS) to \<48 hours and decrease procedural costs, while maintaining safety and increasing patient turnover compared to the standard of care.
Eligibility criteria
Qualifiers
Patient diagnosed with infrarenal Abdominal Aortic Aneurysm (AAA) indicated for elective endovascular repair.
Patient diagnosed with Penetrating Aortic Ulcer (PAU) indicated for elective endovascular repair.
Patient resident in the Bologna metropolitan area OR able to remain within the area for at least 7 days post-procedure.
Patient with a cohabitant or caregiver available (cannot live alone) to ensure safety during the early post-discharge phase.
Disqualifiers
Patient resident outside the Bologna metropolitan area or unable to remain within the area for at least 7 days post-procedure.
Patient without a cohabitant or caregiver available
Common femoral arteries diameter <7 mm
Common femoral arteries with severe calcification (> 50% of vessel circumference), unsuitable for percutaneous closure device
Trial design
Treatments tested in this trial
- Not listed